A Form 4 filed on September 10, 2026 discloses that Christian Stephane Mumenthaler, a director of MetLife, Inc. (NYSE:MET), acquired 21 shares of common stock on September 8, 2026 through dividend reinvestment on deferred shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Key Highlights

  • Reporting person: Christian Stephane Mumenthaler, listed as a Director of MetLife, Inc.
  • Transaction date: September 8, 2026, with the form filed September 10, 2026.
  • Shares acquired: 21 shares of MetLife common stock, coded as an acquisition (A).
  • Price per share: $95.5, described as an imputed reinvestment of dividends on deferred shares.
  • Post-transaction holdings: 3,474 shares of common stock held directly following the reported transaction.
  • Plan basis: The acquisition occurred pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors.

Dividend Reinvestment on Deferred Shares Under MetLife Director Compensation Plan

According to the filing, director Christian Stephane Mumenthaler acquired 21 shares of MetLife, Inc. common stock on September 8, 2026 at a price of $95.5 per share. The filing identifies the transaction code as "A," indicating an acquisition. The shares were added directly to Mumenthaler's beneficial ownership, bringing his total directly held common stock position to 3,474 shares following the transaction.

The filing explains the nature of the acquisition in its footnote: "Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors." The footnote further clarifies that "deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred." No derivative securities were reported in Table II of the filing.

The Form 4 was signed by Morgan Keehner-Jones Mayes as attorney-in-fact on behalf of the reporting person. No amendment date was listed, indicating this is an original filing. The filing reflects no other transactions beyond the single 21-share acquisition described above.

What Was Disclosed

The filing reports that MetLife director Christian Stephane Mumenthaler acquired 21 shares of common stock at $95.5 per share on September 8, 2026, through dividend reinvestment under the company's deferred compensation plan for non-management directors, bringing his direct holdings to 3,474 shares.